Morrison Jodie Pope 4
4 · Q32 Bio Inc. · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Q32 Bio (QTTB) CEO Jodie Morrison Receives 132,000 RSUs
What Happened
Q32 Bio CEO and director Jodie Pope Morrison was granted 132,000 restricted stock units (RSUs) on February 24, 2026. The Form 4 reports the award at $0.00 per unit (a grant, not a purchase), so no cash changed hands in this transaction. RSUs represent a contingent right to receive one share of common stock upon vesting.
Key Details
- Transaction date: February 24, 2026; Form 4 filed March 20, 2026 (appears late versus the usual 2-business-day Form 4 deadline).
- Transaction type: Award/Grant (reported as "A"); 132,000 RSUs granted at $0.00 (total reported $0).
- Shares owned after transaction: not disclosed in the provided filing.
- Vesting (from footnote): 25% vests 6 months after Feb 24, 2026; 25% at 12 months; 25% at 24 months; 25% at 36 months. Each RSU converts to one share upon vesting.
- No 10b5-1 plan, tax withholding, or sale indicated in this filing.
Context
RSU grants are a form of equity compensation and do not involve an immediate market purchase or sale; they simply create a future right to shares subject to vesting. For investors, awards are common for executives and mainly reflect compensation arrangements rather than an immediate endorsement or rejection of the stock. Note the late filing could be of procedural interest, but the grant itself is standard executive compensation.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-24+132,000→ 221,104 total
Footnotes (1)
- [F1]The restricted stock units ("RSUs") vest in four equal installments, 25% shall vest 6 months from February 24, 2026 (the "Grant Date"), 25% shall vest 12 months from the Grant Date, 25% shall vest 24 months from the Grant Date, and 25% shall vest 36 months from Grant Date. Each RSU represents a contingent right to receive one share of Issuer common stock.